1 maxheal pharmaceuticals ltd 11 11 09
DESCRIPTION
An ISO - 9002 and WHO (GMP) certified company, Maxheal Pharmaceuticals is one of the leaders amongst manufacturers and exporters of a vast range of high quality pharmaceutical products and drug formulations. Our range of products includes Anthelmentics, Analgesics, Antipyretics, Antibiotics,B- Lactum, Vitamins, Anti-inflammatory, Anti-Bacterials, CNS and more, which are available in various forms, such as capsules, tablets, drug syrup suspension, injections. Vision To become a global player in Pharmaceutical Business with STRONG presence in all major markets by Year 2015. Mission We are committed to serve the mankind by offering pharmaceutical formulations conforming to international quality norms and parameters.TRANSCRIPT
Welcome to
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
OUR VISIONOUR VISIONTo become a global
player in pharmaceutical
business with strong presence in all major markets worldwide
by 2015.
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
SUCCESS STORY AND SUCCESS STORY AND MILESTONESMILESTONES
Mr. Madan Sakhala, CMD,Maxheal Group of Companies ,begun his journey of success with a retail pharmacy venture in early 80’s.Subsequetly
he took a big leap by setting up a midsize pharmaceutical formulation manufacturing unit. He
quickly sensed opportunity of exports to Africa. African markets accepted Maxheal products due to
its high quality, competitive price and timely deliveries. hereafter Maxheal started growing at
rapid pace .credit for this success and growth goes to Mr. Madan Sakhala’s pharmaceutical knowledge, leadership, team building qualities . Maxheal group
is presently engaged in export to more that 15 countries in Africa ,Asia and Latin America.
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
ACQUISITIONS AND ACQUISITIONS AND ORGANIC GROWTHORGANIC GROWTH
In the year 2008,a wise acquisition move by Maxheal Pharmaceuticals to acquire controlling stakes in M/S Ally Pharma Options Pvt. Ltd has added almost 2 million USD to sales turnover of the Maxheal group of companies. After taking over Ally Pharma its sales is expected to touch 4 million USD in the year 2009-10.this acquisition has also made available to Maxheal much needed additional manufacturing capacity to cater to ever growing west and East Africa market and enabled us to plan growth in newer territories .
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
ALLY PHARMA OPTION’S manufacturing facility is already approved by many African regulatory authorities such as Kenya, Uganda, Ghana, Nigeria. more
regulatory approvals from countries such as Malawi, Ethiopia, Sudan, Yemen are planned in near future.
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
ACQUISITIONS AND ACQUISITIONS AND ORGANIC GROWTHORGANIC GROWTH
The ALLY PHARMA has facility to manufacture dosage forms such as ointments, liquid orals, dusting powders in addition to tablets and capsules. Now we are able to supply almost all routine dosage forms that are required by pharmaceuticals distributors worldwide.
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
NEW CORPORATE OFFICENEW CORPORATE OFFICE
To cope with expanding business, an ultra modern office with best connectivity and I.T. Infrastructure is being built and will be inaugural in year 2010.This will be four storied building with capacity to accommodate over 200 employees
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
FINANCIAL STRENGTH AND FINANCIAL STRENGTH AND STRATEGY FOR EXPANSION AND STRATEGY FOR EXPANSION AND
DIVERSIFICATIONDIVERSIFICATIONLand, Machinery, Intellectual Assets, Market Capitalization, Office Space, all put together, Maxheal Group’s current Net Worth is over 50 Million USD.
Maxheal is planning a “Initial Public Offering ” of sizeable amount in Indian Stock Market by third quarter of 2010 to raise funds for further expansion and diversification of Surat plant.
Maxheal is accredited “SE 2A” rating in S.M.E. sector by NSIC-CRISIL.
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
DIVERSIFICATION PLANS AND DIVERSIFICATION PLANS AND BUSINESS DEVELOPMENT STRATEGYBUSINESS DEVELOPMENT STRATEGY
With number of local manufacturers growing in many countries, Maxheal plans to set up independent facility and cater to these manufactures by supplying them semi-finished products such as D. C. granules, drug loaded pallets, taste masked granules etc. Maxheal has in-house printing and packing unit, we plan to supply packing material to overseas manufacturers.
We plan to acquire more marketing authorizations from European companies to strengthen our niche product segment which currently contains C.N.S. category.
• In line with our aspiration to be in niche product market segment in Europe we have acquired products from Rodleben (Germany). These products have valid German Marketing Authorizations and are Planned to be manufactured in our Surat manufacturing facility.
• Following products will be registered and marketed in other EU countries by approaching various European partners either by forming joint venture companies or out-licensed to them with a pre-condition of up-front fee and long term supply agreement.
Product name api application form ENR
Doxepin-RPh 100mg Doxepin film coated tablets 2149104
Doxepin-RPh 50 mg Doxepin film coated tablets 2149103
Fluoxetin-RPh 20mg Fluoxetin hard gelatine capsules 2139488
Levodopa-Carbidopa-RPh 100/25mg
Levodopa tablets 2145925
Levodopa-Carbidopa-RPh 200/50mg
Levodopa tablets 2148797
Melperon-RPh 100mg Melperon tablets 2139518
Melperon-RPh 25mg Melperon tablets 2139517
Melperon-RPh Saft Melperon juice 2139519
Sulpirid-RPh 200mg Sulpirid tablets 2138340
Sulpirid-RPH 50mg Sulpirid hard gelatine capsules 2138310
Valproat-RPh 150mg Valproatgastric juice stable film coated tablets
2148779
Valproat-RPh 300mg Valproatgastric juice stable film coated tablets
2148780
Valproat-RPh 600mg Valproatgastric juice stable film coated tablets
2148781
Valproat-RPh Loesung Valproat solution 2148782
COMMITTED FOR GLOBAL HEALTH
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
tEUROPEAN PRODUCT DOSSIERS AND MAsEUROPEAN PRODUCT DOSSIERS AND MAs
For Maxheal Pharma’s Nashik Plant: Item Annual Capacity Tablets 54,00,00,000 Nos. Capsules 84,00,00,000 Nos. Syrup (Dry) 180000 Ltrs. For Maxheal Pharma’s Surat Plant: Item Annual Capacity Tablets 1,000,000,000 Nos. Capsules 60,00,000 Nos.
COMMITTED FOR GLOBAL HEALTH
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
Qu
ality
.
Perf
orm
an
ce.
Imp
rovem
en
tMANUFACTURING CAPABILITIESMANUFACTURING CAPABILITIES
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
FOR ALLY PHARMA BOISAR FOR ALLY PHARMA BOISAR PLANTPLANT
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Maxheal Pharma’s Q.C. and R&D is equipped with latest instruments and manned by highly experienced and intelligent
professionals
QC & R&DQC & R&D
COMMITTED FOR GLOBAL HEALTH
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
Qu
ality
.
Perf
orm
an
ce.
Imp
rovem
en
t• Team of techno-marketing professionals well versed with country-
specific regulatory information.• Participation in Trade Exhibitions.• Product packs and designs with international look and appeal.• Excellent support to the Distributors through training, provision of
Promotional Products, gifts.
MARKETING STRENGTHMARKETING STRENGTH
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
We are committed to social and medical well being of people worldwide. We achieved this by offering best quality and competitively priced pharmaceutical & allied products to
patients through our vast network of distributors and contract manufacturing
partners.
Maxheal supports various social and community based development programs.
OUR COMMITMNET TOWARDS OUR COMMITMNET TOWARDS SOCIETY & HEALTH OF PEOPLESOCIETY & HEALTH OF PEOPLE
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
All our manufacturing processes and distribution practices are designed and
executed in such a way as to avoid damage to the
environment
OUR CONCERN FOR ENVIRONMENTOUR CONCERN FOR ENVIRONMENT
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
WHO GMP Certified Company ISO-2008-9000 Certified
‘Niryat Shree’ Award For Excellent Export Sales
Possessing " Two Star Export House" Status
RECOGNITIONSRECOGNITIONS
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Supply of pharmaceuticals to distributors across the globe.
Contract manufacturing (only for reputed overseas pharmaceutical companies)
Participation in tenders of various governmental and non-governmental agencies.
We handle turn-key pharmaceutical manufacturing projects and technology transfer.
We act as sourcing partners for our overseas clients for all their pharmaceutical and medico-surgical procurements.
We can offer formulation development services to companies worldwide.
OUR BUSINESS SEGMENTSOUR BUSINESS SEGMENTS
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Dynamic and ambitious leadership with excellent business acumen.
Driven by commitment to exceed customer’s expectations
Own pharmaceutical manufacturing facilities at three locations In India.
Over 500 well qualified and experienced workforce.
Alert and dedicated Quality Assurance team
Knowledgeable and hardworking R & D and Regulatory Affairs persons.
Modern machineries capable of handling huge order volumes.
Manufacturing facilities well connected rail and road.
Prompt and sharp finance &logistics department.
OUR STRENGTHSOUR STRENGTHS
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Finished Pharmaceutical Formulations
Nutraceuticals
APIs
Semi - Finished Formulations
Drug Loaded Pallets & Ready To Compress Tablet Premix
Pharmaceutical Machinery
Contract Formulation Development
Pharmaceutical Manufacturing Turn-key Projects
OUR PRODUCTS AND OUR PRODUCTS AND SERVICESSERVICES
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
MAXHEAL PHARMACEUTICALS
Board of Directors
SR. NO.
NAME DESIGNATION OCCUPATION
1Mr. Madan M. Sakhala
ManagingDirector
Business
2Mrs. Hemlata M. Sakhala
Director Business
3 Mr. Mehul M. SakhalaDirector
Business
Above persons are also directors of Ally Pharma Options Pvt Ltd, A Subsidiary of Maxheal group Of companies.
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Experienced Management with Proven Track Record
Name Designation Qualifications
Experience (In Years)
Mr. P.V.Mannur.
General Manager- operation
B. Pharm. 34 years
Mr. Nandkishore Deshpande
Manager – (QA/QC)
M.Sc. (Analytical Chemistry)
30 years
Mr. Anil Choudhary.
Manager- Production
M. Pharm. 15 years
Mr. Sanjay Gawali
Sr. Manager –International
Marketing
M. Pharm. 22years
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Experienced Management with Proven Track Record
Name Designation Qualifications
Experience (In Years)
Mr. Sushil Purohit.
General Manager – Accounts &
Finance
FCA/ C.S. Inter
11 years
Mr. Kailas Somani.
Manager- Purchase
B.Sc 32 years
Mr. Rajnish Singh.
Manager – IT CIC, PTM NIIT 10 years
Mr.Amit Shandilya
Manager-Q.C.
Mr.Praful Vyas Mr.Uday Savant
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Key Performance IndicatorSALES FIGURES
PAST PRESENT AND FUTURE
44595344
7300
8500
10000
0
10002000
30004000
50006000
70008000
900010000
2007 ( 2008 2009 2010 2011
Rs. In Lacs
YEARSCAGR FOR THE PERIOD 2007-2009 IS 16 %
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Key Performance Indicator Profitability
Rs.in lacs
198
470
384
758
0
100
200
300
400
500
600
700
800
2006 2007 2008 2009
YEARS
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Immediate Release And Sustained Tablet And Capsule Formulations.
Ointments
Syrups and Suspensions
Beta-lactam tablets &capsules,
Liquid and dry powder injections
Small Volume Parenterals and Large Volume Parenterals
DOSAGEDOSAGE FORMS AVAILABLE/PROPOSEDFORMS AVAILABLE/PROPOSED
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
THERAPEUTIC SEGMENT WE MANAGETHERAPEUTIC SEGMENT WE MANAGE
C.N.S.
C.V.S
G.I.DISEASES
ANTIBIOTICS AND ANTI-INFECTIVES
ARVs
ANTI-TUBERCULAR
ANTI-MALERIAL
VITAMINS AND MINERALS
ANALGESICS AND ANTI-INFLAMMATORY
HORMONES(PROPOSED)
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
REGULATORY APPROVALS (SEMI-REGUALTED MARKETS)- UNITWISEREGULATORY APPROVALS (SEMI-REGUALTED MARKETS)- UNITWISE
REGULATORY AUTHRORITIES
UNIT-I-NASIK UNIT-II- SACHIN UNIT-III-TARAPUR
NAFDAC-NIGERIA YES PROPOSED YES
NDA UGANDA PROPOSED PROPOSED YES
MEDICINE AND POISON BOARD-KENYA
PROPOSED PROPOSED YES
FDB-GHANA PROPOSED PROPOSED YES
YEMEN-MOH PROPOSED PROPOSED PROPOSED
SUDAN-MOH PROPOSED PROPOSED PROPOSED
POISON BOARD-MALAWI PROPOSED PROPOSED PROPOSED
REGULATORY APPROVALS (SEMI-REGUALTED MARKETS)- UNIT-II-SACHINREGULATORY APPROVALS (SEMI-REGUALTED MARKETS)- UNIT-II-SACHIN
MHRA-UK PROPOSED MOH-GCC PROPOSED
TGA-AUSTRALIA PROPOSED ANVISA-BRAZIL PROPOSED
MCC-SOUTH AFRICA PROPOSED EU-GMP PROPOSED
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Our product quality and excellent customer service has helped us grow successfully in all the geographies.
We have sizable market share in countries like Nigeria, Ghana, Kenya, Uganda. Ivory Coast, Costa Rica, Cambodia, Vietnam And
Philippines
We are growing at rapid pace in other markets such as Iraq, Afghanistan and many CIS and Latin American countries.
With acquisition of German dossiers we plan to enter European markets. We would be able to trigger MHRA and EU-GMP
inspections of our Surat Plant by manufacturing these German dossier products in our Surat Plant.
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Backed By Over 25 Years Of international experience In Pharmaceutical Manufacturing And Marketing Of Our Visionary Leader Mr.Madan Sakhala, We are poised to enter into an exponential growth phase and thus are looking for likeminded pharmaceutical enterprises across the globe who want to grow with us
WE INVITE BUSINESS PROPOSALS WE INVITE BUSINESS PROPOSALS FORFOR
Distributorship.
Manufacturing joint venture.
Contract manufacturing.
Co-marketing for brand building.
Setting up of overseas office for trade and marketing.
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
Q
uality
.
Perf
orm
an
ce.
Imp
rovem
en
t
COMMITTED FOR GLOBAL HEALTH
THANKING YOU THANKING YOU
AND AND
LOOKING FORWARD LOOKING FORWARD TO BUILD A LONG LASTING TO BUILD A LONG LASTING
BUSINESS RELATIONSHIP !BUSINESS RELATIONSHIP !
WARM REGARDS,WARM REGARDS,
MAXHEAL FAMILYMAXHEAL FAMILY